Medtronic

Medtronic, Inc. is a provider of medical technology products and is headquarted in Minneapolis, Minnesota. As part of their Diabetes business, they offer the only FDA-approved integrated diabetes management system consisting of an insulin pump, continuous glucose monitoring (CGM) and therapy management software. Patients can use the CareLink online service to gather information from their Medtronic Insulin Pump and other devices. The company has a broad range of career opportunities available to job seekers and currently employs 38,000 people.

Discover

Website: Medtronic.com

Hashtag: #Medtronic


Medtronic CEO On the Company’s AI: This Isn’t About ChatGPT

Medtronic CEO On the Company’s AI: This Isn’t About ChatGPT

January 8, 2024 1:51 pm by | 0 Comments

Geoff Martha sought to establish a clear line between popular understanding of AI created by apps like ChatGPT and what he believes is the significant impact that Medtronic’s AI-enabled products are already having on patients and other healthcare stakeholders today.


Should More Doctors Be on TikTok? This One Says Yes

Should More Doctors Be on TikTok? This One Says Yes

September 20, 2023 3:49 pm by | 0 Comments

Gastroenterologist Dr. Austin Chiang has about a decade of experience as a physician influencer on social media. During a conference in Chicago, he encouraged more providers to share their expertise on social media. By having a presence on these platforms, healthcare professionals demonstrate their commitment to meeting patients where they are, he said.



Newly Public Allurion Aims to Show How Med Tech Can Complement Obesity Drugs

Newly Public Allurion Aims to Show How Med Tech Can Complement Obesity Drugs

August 2, 2023 6:44 pm by | 0 Comments

Allurion Technologies has commercialized a gastric balloon in the form of a pill that patients swallow. But the weight loss platform from the now NYSE-listed company also includes AI-driven software that provides insights about a patient’s progress, technology with the potential for use alongside obesity drugs.


Medtronic Gains FDA Approval for Newest Insulin Pump

Medtronic Gains FDA Approval for Newest Insulin Pump

April 25, 2023 5:16 pm by | 0 Comments

Medtronic recently received FDA approval for its MiniMed 780G system, which is an insulin pump that automatically adjusts and corrects type 1 diabetes patients’ glucose levels every five minutes. The news comes two years after Medtronic submitted the system for FDA approval and three years after the company began selling the product in Europe.


Nvidia, Medtronic Partner to Create AI Platform for Medical Devices

Nvidia, Medtronic Partner to Create AI Platform for Medical Devices

March 21, 2023 7:18 pm by | 0 Comments

Nvidia and Medtronic recently announced a collaboration focused on embedding AI into medical devices. The two companies plan to create marketplace for AI applications that will allow developers and clinicians to develop their own algorithms to use on Medtronic’s medical devices.


Weight Loss in a Pill Device Firm Allurion Heads to NYSE via SPAC Merger

Weight Loss in a Pill Device Firm Allurion Heads to NYSE via SPAC Merger

February 9, 2023 6:45 pm by | 0 Comments

Allurion Technologies has developed a gastric balloon that does not require surgery. The merger deal taking Allurion public comes as the company continues global commercialization of its technology.


Abbott Enters TAVI Device Market Dominated by Edwards, Medtronic

Abbott Enters TAVI Device Market Dominated by Edwards, Medtronic

January 19, 2023 5:21 pm by | 0 Comments

Abbott recently earned FDA approval for its latest transcatheter aortic valve implantation (TAVI) system, which is named Navitor. Abbott will have to fight for its place the U.S. TAVI device space, as the systems made by Edwards and Medtronic have a steadfast command of the market share.



Medtronic serves up platform for stroke-care startups

Medtronic serves up platform for stroke-care startups

October 28, 2022 3:32 pm by | 0 Comments

The innovation platform promises to match entrepreneurs with the resources they need to advance treatments for stroke care but also to help the device maker process all the new ideas it sees.


Skeptical of future performance, spooked by recent misses, Needham analyst downgrades Medtronic’s stock

Skeptical of future performance, spooked by recent misses, Needham analyst downgrades Medtronic’s stock

May 27, 2022 1:47 pm by | 0 Comments

Mike Matson evaluated two earlier negative bits of information along with Thursday’s revenue and earnings-per-share miss to conclude that Medtronic’s stock, which has held up despite recent market swings, needs to be downgraded to a “hold” from a “buy”.


Using AI to reduce false alerts for patients with heart monitoring devices to detect cardiac arrhythmias

Using AI to reduce false alerts for patients with heart monitoring devices to detect cardiac arrhythmias

May 26, 2022 7:30 am by | 0 Comments (Sponsored)

An infographic illustrates how Medtronic’s AccuRhythm AI suppresses false alerts while maintaining sensitivity.


With the FTC’s conditional approval, Medtronic completes its $1.1B acquisition of Intersect ENT

With the FTC’s conditional approval, Medtronic completes its $1.1B acquisition of Intersect ENT

May 13, 2022 1:16 pm by | 0 Comments

To get approval for the deal, Medtronic agreed to sell an Intersect subsidiary to soothe the FTC’s concerns.


Key takeaways from Medtronic CEO’s presentation at virtual JPM conference

Key takeaways from Medtronic CEO’s presentation at virtual JPM conference

January 10, 2022 4:16 pm by | 0 Comments

Geoff Martha participated in the 40th annual J.P. Morgan Healthcare conference virtually explaining key decisions, accepting responsibility for a trifecta of bad news while also signaling that all will be well in the future at the Dublin-based medtech giant.


Medtronic hit with FDA warning letter for diabetes devices

Medtronic hit with FDA warning letter for diabetes devices

December 15, 2021 2:23 pm by | 0 Comments

The company received a warning letter on Wednesday related to inadequate quality requirements at the headquarters for its diabetes business. It comes after Medtronic expanded a recall of its MiniMed 600 series insulin pumps.


Medtronic expands recall of MiniMed insulin pumps 

Medtronic expands recall of MiniMed insulin pumps 

October 6, 2021 5:05 pm by | 0 Comments

Medtronic is expanding a recall of two of its MiniMed 600 series insulin pumps after reports found several had broken retainer rings cracked, resulting in insulin doses that were too high or too low. 


Why Medtronic decided to move now on its $1.1B Intersect ENT deal 

Why Medtronic decided to move now on its $1.1B Intersect ENT deal 

August 12, 2021 3:49 pm by | 0 Comments

Investors had long expected Intersect ENT to be an acquisition target before Medtronic announced its plans to buy the company last week. Better reimbursement for Intersect ENT’s products and elective procedures returning over the summer months might have helped the deal cross the finish line.